Fredrik J. Swartling

BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma

Pratiti Bandopadhayay, Guillaume Bergthold, Brian T. Nguyen et al. · Clinical Cancer Research · 2013 · 351 citations · Full text

Medicine, Oncology, Pharmacology +13

Non-Stem Cell Origin for Oligodendroglioma

Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling et al. · Cancer Cell · 2010 · 236 citations · Full text

Medicine, Cell Biology, Oncology +12

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Rebecca M. Hill, Sanne Kuijper, Janet C. Lindsey et al. · Cancer Cell · 2014 · 213 citations · Full text

Medicine, Genetics, Oncology +17

Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC

Fredrik J. Swartling, Vasil Savov, Anders I. Persson et al. · Cancer Cell · 2012 · 211 citations · Full text

Medicine, Cancer Biology, Oncology +12

Pleiotropic role for<i>MYCN</i>in medulloblastoma

Fredrik J. Swartling, Matthew Grimmer, Christopher S. Hackett et al. · Genes & Development · 2010 · 174 citations · Full text

Medicine, Oncology, Pathology +17